# FDA 483 - Kamran Qureshi, M.D. - April 28, 2023

Source: https://www.globalkeysolutions.net/records/483/kamran-qureshi-md/9e902e79-e94d-4e14-bb08-3468473ee43d

> FDA 483 for Kamran Qureshi, M.D. on April 28, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Kamran Qureshi, M.D.
- Inspection Date: 2023-04-28
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West II
- Summary: An FDA inspection of Kamran Qureshi, M.D. in Saint Louis, MO, identified a significant issue regarding the conduct of an investigation. The clinical investigator failed to maintain control and accountability for study drugs, specifically eleven missing study kits. This indicates a serious lapse in adherence to the investigational plan and regulatory requirements for drug management.

## Related Officers

- [Carmen Y. Fisher](https://www.globalkeysolutions.net/people/carmen-y-fisher/d41b9f1a-1a29-4b1c-bd64-acedde50302a)

Company: https://www.globalkeysolutions.net/companies/kamran-qureshi-md/e331ccff-2e98-4bc4-b980-353bf4612c1d

Office: https://www.globalkeysolutions.net/offices/division-of-human-and-animal-food-operations-west-ii/8851d151-0390-4d17-be66-fd86d12aa6b8